Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease

Diabetes Care

Volumn 30, Issue 3, 2007, Pages 670-676

  Lapolla, Annunziata ^a   Piarulli, Francesco ^a   Sartore, Giovanni ^a   Ceriello, Antonio ^b   Ragazzi, Eugenio ^a   Reitano, Rachele ^a   Baccarin, Lorenzo ^a   Laverda, Barbara ^a   Fedele, Domenico ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; ANTIOXIDANT; GLYCOLIPID; MALONALDEHYDE; PENTOSIDINE;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CAROTID ARTERY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; FEMALE; HUMAN; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; ANTIOXIDANTS; ARTERIAL OCCLUSIVE DISEASES; BLOOD FLOW VELOCITY; BODY MASS INDEX; BRACHIAL ARTERY; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; VITAMIN E;

EID: 33847671460     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1508     Document Type: Article

References (45)

1. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham study. JAMA 241:2035-2038, 1979
2. Vlassara H, Palace MR: Diabetes and advanced glycation end products. J Intern Med 251:87-101, 2002
3. Yan SF, Ramasamy R, Naka Y, Schmidt AM: Glycation, inflammation and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93:1159-1169, 2003
4. Basta G, Schmidt AM, De Caterina R: Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63:582-592, 2004
5. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 4:813-820, 2001
6. Giuliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
7. Ceriello A, Bortolotti N, Falleti E, Taboga C, Tonutti L, Crescentini A, Motz E, Lizzio S, Russo A, Bartoli E: Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care 20:194-197, 1997
8. Ono Y, Aoki S, Ohnishi K, Yasuda T, Kawano K, Tsukada Y: Increased serum levels of advanced glycation end-products and diabetic complications. Diabetes Res Clin Pract 41:131-137, 1999
9. Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF: Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 22:1543-1548, 1999
10. Aso Y, Inukai T, Tayama K, Takemura Y: Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. Acta Diabetol 37:87-92, 2000
11. Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguci Y, Kagoshima T, Dohi K, Makita Z, Vlassara H, Bucala R: Immunohistochemical localization of advanced glycosilation endproducts in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol 143:1649-1656, 1993
12. Yoshida N, Okumura K, Aso Y: High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism 54:345-350, 2005
13. Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, Cloarec L: Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 214:227-234, 1993
14. Zheng ZJ, Sharret AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, Dobs A, Evans GW, Heiss G: Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 131:115-125, 1997
15. Leng GC, Fowkes FGR, Lee AJ, Dunbar J, Housley E, Ruckley CV: Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 313:1440-1444, 1996
16. Walters DP, Gatling W, Mullee MA, Hill RD: The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabet Med 9:710-715, 1992
17. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JC, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286:1317-1324, 2001
18. Prineas RJ: The Minnesota Manual of Electrographic findings. Crow RS, Blackburn H, Eds. Bristol, Jhon Wright Press, 1982
19. American Diabetes Association: Standards of medical care in diabetes - 2006 (Position Statement). Diabetes Care 29 (Suppl. 1):S4-S42, 2006
20. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167, 2003
21. Lapolla A, Piarulli F, Sartore G, Rossetti C, Martano L, Carraro P, De Paoli M, Fedele D: Peripheral artery disease in type 2 diabetes: the role of fibrinolysis. Thromb Haemost 89:91-96, 2003
22. Odetti P, Fogarthy J, Sell D, Monnier VM: Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41:153-159, 1992
23. Makita Z, Vlassara, H Cerami A, Bucala R: Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138, 1992
24. Ghiselli A, Serafini M, Maiani G, Azzini E, Ferro-Luzzi A: A fluorescence-based method for measuring total plasma antioxidant capacity. Free Radic Biol Med 18:29-36, 1995
25. Vitamins and coenzymes, part F. In Methods in Enzymology, vol. 67. McCormick DB, Wright LD, Eds. New York, Academic Press, 1980
26. Conti M, Morand PC, Levillain P, Lemonnier A: Improved fluorometric determination of malonaldehyde. Clin Chem 37:1273-1275, 1991
27. Huggett AST, Nixon DA: Use of glucose oxidase peroxidase and O-dianisine in the determination of blood and urine glucose. Lancet 2:368-370, 1957
28. Jaynes PK; Willis MC, Chon PP: Evaluation of minicolumn chromatographic procedure for the measurement of HbA1c. Clin Biochem 39:2162-2165, 1993
29. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475, 1974
30. Lipid Research Clinics Program. Lipid and lipoprotein analysis. In Manual of Laboratory Operations, 2nd ed. Washington, DC, U.S. Department of Health and Human Services, 1982, p. 63-77
31. Fossati P, Prencipe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-2080, 1982
32. Armitage P: Statistical Methods in Medical Research. Oxford, Blackwell Scientific Publications, 1971
33. Xia X, Xie Z: AMADA: analysis of microarray data. Bioinformatics 17:569-570, 2001
34. Lipkovich I, Smith EP: BiPlot and singular value decomposition macros for Excel. J Stat Software 7:1-15, 2002
35. Aitchinson J, and Greenacre M: Biplots of compositional data. Applied Statistics 51:375-392, 2002
36. Piarulli F, Lapolla A, Sartore G, Rossetti C, Bax G, Noale M, Minicuci N, Fiore C, Marchioro L, Manzato E, Fedele D: Auto-antibodies against oxidized LDLs and atherosclerosis in type 2 diabetes. Diabetes Care 28:653- 657, 2005
37. Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF: Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 337:1-5, 1991
38. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WC: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444-1449, 1993
39. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Rosner B, Willet WC: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450-1456, 1993
40. Jones AF, Winkles JW, Jennings PE, Florkoski CM, Lunec J, Barnett AH: Serum antioxidant activity in diabetes mellitus. Diabetes Res 7:89-92, 1988
41. Strain J: Disturbances of micronutrient and antioxidant status in diabetes. Proc Nutr Soc 50:591-604, 1991
42. Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF Gernstein HC: Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICROHOPE substudy. Diabetes Care 25:1919-1927, 2002
43. The Heart Outcomes Prevention Evaluation Study Investigators: Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 342:154-160, 2000
44. Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Rognoni G, Nicolucci A: Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 26:3264-3272, 2003
45. Osmundson PJ, O'Fallon WM, Clements IP, Kazmier BR, Palumbo PJ: Reproducibility of noninvasive tests of peripheral occlusive arterial disease. J Vasc Surg 2:678-683, 1985